RNA Interference (RNAi) Drug Delivery Market Report

Global and China RNA Interference (RNAi) Drug Delivery Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 05, 2022
  • PAGES：190
  • REPORT CODE：GMM1438163
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the RNA Interference (RNAi) Drug Delivery industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Tacere Therapeutics Inc

    • Sirnaomics Inc

    • Calondo Pharmaceuticals Inc

    • Marina Biotech Inc

    • Access Pharmaceuticals Inc

    • Metabolic disorders

    • Alnylam Pharmaceuticals Inc

    • RXi Pharmaceuticals Corp

    • Silence Therapeutics plc

    • Merck & Co Inc

    • Dicerna Pharmaceuticals Inc

    • PhaseRx Inc

    • Quark Pharmaceuticals Inc

    • Traversa Therapeutics Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Nanoparticle Drug Delivery Technology

    • Pulmonary Drug Delivery Technology

    • Nucleic Acid Drug Delivery Technology

    • Aptamer Drug Delivery Technology

    Application:

    • Infectious Diseases

    • Cardiology

    • Oncology

    • Neurology

    • Ophthalmology

    • Metabolic Disorders

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 RNA Interference (RNAi) Drug Delivery Industry Overview

      • 1.1.1 RNA Interference (RNAi) Drug Delivery Market Scope and Market Segments

      • 1.1.2 RNA Interference (RNAi) Drug Delivery Industry Characteristics

      • 1.1.3 Global and China RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China RNA Interference (RNAi) Drug Delivery Production Value and Growth Rate (2017-2028)

    • 1.2 Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Nanoparticle Drug Delivery Technology

      • 1.2.2 Pulmonary Drug Delivery Technology

      • 1.2.3 Nucleic Acid Drug Delivery Technology

      • 1.2.4 Aptamer Drug Delivery Technology

    • 1.3 Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Infectious Diseases

      • 1.3.2 Cardiology

      • 1.3.3 Oncology

      • 1.3.4 Neurology

      • 1.3.5 Ophthalmology

      • 1.3.6 Metabolic Disorders

    • 1.4 Market Analysis by Region

      • 1.4.1 North America RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global RNA Interference (RNAi) Drug Delivery Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global RNA Interference (RNAi) Drug Delivery Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China RNA Interference (RNAi) Drug Delivery Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China RNA Interference (RNAi) Drug Delivery Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global RNA Interference (RNAi) Drug Delivery Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 RNA Interference (RNAi) Drug Delivery Industry Porter's Five Forces Model Analysis

      • 2.2.3 RNA Interference (RNAi) Drug Delivery Industry PEST Analysis

    • 2.3 RNA Interference (RNAi) Drug Delivery Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 RNA Interference (RNAi) Drug Delivery Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on RNA Interference (RNAi) Drug Delivery Industry

    Chapter 3 Global and China RNA Interference (RNAi) Drug Delivery Market, by Manufacturer

    • 3.1 Global and China RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China RNA Interference (RNAi) Drug Delivery Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China RNA Interference (RNAi) Drug Delivery Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China RNA Interference (RNAi) Drug Delivery Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China RNA Interference (RNAi) Drug Delivery Market Top 3 Players

    Chapter 4 Global and China RNA Interference (RNAi) Drug Delivery Market, by Type (2017-2028)

    • 4.1 RNA Interference (RNAi) Drug Delivery Market Trend, by Type

    • 4.2 Global RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global RNA Interference (RNAi) Drug Delivery Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global RNA Interference (RNAi) Drug Delivery Price Trend, by Type (2017-2028)

    • 4.3 China RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China RNA Interference (RNAi) Drug Delivery Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China RNA Interference (RNAi) Drug Delivery Price Trend, by Type (2017-2028)

    Chapter 5 Global and China RNA Interference (RNAi) Drug Delivery Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global RNA Interference (RNAi) Drug Delivery Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China RNA Interference (RNAi) Drug Delivery Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China RNA Interference (RNAi) Drug Delivery Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America RNA Interference (RNAi) Drug Delivery Market Analysis

    • 7.1 North America RNA Interference (RNAi) Drug Delivery Market, by Type

    • 7.2 North America RNA Interference (RNAi) Drug Delivery Market, by Application

    • 7.3 North America RNA Interference (RNAi) Drug Delivery Market Analysis and Forecast, by Country

      • 7.3.1 United States RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe RNA Interference (RNAi) Drug Delivery Market Analysis

    • 8.1 Europe RNA Interference (RNAi) Drug Delivery Market, by Type

    • 8.2 Europe RNA Interference (RNAi) Drug Delivery Market, by Application

    • 8.3 Europe RNA Interference (RNAi) Drug Delivery Market Analysis and Forecast, by Country

      • 8.3.1 Germany RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC RNA Interference (RNAi) Drug Delivery Market Analysis

    • 9.1 APAC RNA Interference (RNAi) Drug Delivery Market, by Type

    • 9.2 APAC RNA Interference (RNAi) Drug Delivery Market, by Application

    • 9.3 APAC RNA Interference (RNAi) Drug Delivery Market Analysis and Forecast, by Country

      • 9.3.1 China RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Market Analysis

    • 10.1 Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Market, by Type

    • 10.2 Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Market, by Application

    • 10.3 Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina RNA Interference (RNAi) Drug Delivery Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China RNA Interference (RNAi) Drug Delivery Company Profiles

      • 11.1 Tacere Therapeutics Inc

        • 11.1.1 Tacere Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.1.3 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Sirnaomics Inc

        • 11.2.1 Sirnaomics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.2.3 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Calondo Pharmaceuticals Inc

        • 11.3.1 Calondo Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.3.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Marina Biotech Inc

        • 11.4.1 Marina Biotech Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.4.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Access Pharmaceuticals Inc

        • 11.5.1 Access Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.5.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Metabolic disorders

        • 11.6.1 Metabolic disorders Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Metabolic disorders RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.6.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Alnylam Pharmaceuticals Inc

        • 11.7.1 Alnylam Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.7.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 RXi Pharmaceuticals Corp

        • 11.8.1 RXi Pharmaceuticals Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Silence Therapeutics plc

        • 11.9.1 Silence Therapeutics plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.9.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Merck & Co Inc

        • 11.10.1 Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Merck & Co Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.10.3 Merck & Co Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Dicerna Pharmaceuticals Inc

        • 11.11.1 Dicerna Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.11.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 PhaseRx Inc

        • 11.12.1 PhaseRx Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.12.3 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Quark Pharmaceuticals Inc

        • 11.13.1 Quark Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.13.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Traversa Therapeutics Inc

        • 11.14.1 Traversa Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Profiles, Application and Specification

        • 11.14.3 Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 RNA Interference (RNAi) Drug Delivery Industry Investment Prospect and Risk Assessment

    • 12.1 RNA Interference (RNAi) Drug Delivery Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 RNA Interference (RNAi) Drug Delivery Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Production Value and Growth Rate (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Production Value and Growth Rate (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Nanoparticle Drug Delivery Technology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Pulmonary Drug Delivery Technology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Nucleic Acid Drug Delivery Technology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Aptamer Drug Delivery Technology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Infectious Diseases (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Cardiology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Oncology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Neurology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Ophthalmology (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Market Size and Growth Rate of Metabolic Disorders (2017-2028)

    • Figure North America RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China RNA Interference (RNAi) Drug Delivery Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China RNA Interference (RNAi) Drug Delivery Sales Value, by Manufacturer (2021&2022)

    • Table Global and China RNA Interference (RNAi) Drug Delivery Market Share, by Manufacturer (2021&2022)

    • Figure Global and China RNA Interference (RNAi) Drug Delivery Market Share, by Manufacturer in 2021

    • Figure Global and China RNA Interference (RNAi) Drug Delivery Market Share, by Manufacturer in 2022

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Volume, by Type (2017-2028)

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Value, by Type (2017-2028)

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Value Share, by Type (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Price Trend, by Type (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Volume, by Type (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Value, by Type (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Value Share, by Type (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Price Trend, by Type (2017-2028)

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Volume, by Application (2017-2028)

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Value, by Application (2017-2028)

    • Table Global RNA Interference (RNAi) Drug Delivery Sales Value Share, by Application (2017-2028)

    • Figure Global RNA Interference (RNAi) Drug Delivery Sales Value Share, by Application (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Volume, by Application (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Value, by Application (2017-2028)

    • Table China RNA Interference (RNAi) Drug Delivery Sales Value Share, by Application (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Sales Value Share, by Application (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure North America RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure Europe RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure APAC RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Production, Import, Consumption and Export (2017-2022)

    • Table North America RNA Interference (RNAi) Drug Delivery Sales Volume, by Type (2017-2028)

    • Table North America RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure North America RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table North America RNA Interference (RNAi) Drug Delivery Sales Volume, by Application (2017-2028)

    • Table North America RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure North America RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure United States RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Canada RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Canada RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Mexico RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table Europe RNA Interference (RNAi) Drug Delivery Sales Volume, by Type (2017-2028)

    • Table Europe RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure Europe RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table Europe RNA Interference (RNAi) Drug Delivery Sales Volume, by Application (2017-2028)

    • Table Europe RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Europe RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Germany RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Germany RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure UK RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure UK RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure France RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure France RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Italy RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Italy RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Spain RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Spain RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Belgium RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Poland RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Poland RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Russia RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Russia RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Turkey RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table APAC RNA Interference (RNAi) Drug Delivery Sales Volume, by Type (2017-2028)

    • Table APAC RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure APAC RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table APAC RNA Interference (RNAi) Drug Delivery Sales Volume, by Application (2017-2028)

    • Table APAC RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure APAC RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure China RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Japan RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Japan RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure India RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure India RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure South Korea RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Brazil RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure South Africa RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Figure Argentina RNA Interference (RNAi) Drug Delivery Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina RNA Interference (RNAi) Drug Delivery Sales Value and Growth Rate (2017-2028)

    • Table Tacere Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tacere Therapeutics Inc Product Profiles, Application and Specification

    • Table Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sirnaomics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sirnaomics Inc Product Profiles, Application and Specification

    • Table Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Calondo Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Calondo Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Marina Biotech Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Marina Biotech Inc Product Profiles, Application and Specification

    • Table Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Access Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Access Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Metabolic disorders Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Metabolic disorders Product Profiles, Application and Specification

    • Table Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alnylam Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alnylam Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table RXi Pharmaceuticals Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table RXi Pharmaceuticals Corp Product Profiles, Application and Specification

    • Table RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Silence Therapeutics plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Silence Therapeutics plc Product Profiles, Application and Specification

    • Table Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co Inc Product Profiles, Application and Specification

    • Table Merck & Co Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dicerna Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dicerna Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PhaseRx Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PhaseRx Inc Product Profiles, Application and Specification

    • Table PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Quark Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Quark Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Traversa Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Traversa Therapeutics Inc Product Profiles, Application and Specification

    • Table Traversa Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US